Hypercytokinemia and Pathogen-Host Interaction in COVID-19
- PMID: 32606886
- PMCID: PMC7320995
- DOI: 10.2147/JIR.S259096
Hypercytokinemia and Pathogen-Host Interaction in COVID-19
Abstract
Severe acute respiratory syndrome (SARS) coronavirus (CoV)-2 (SARS-CoV-2) is a novel coronavirus identified as the cause of coronavirus disease-2019 (COVID-19) that began in Wuhan, China in late 2019 and spread now in 210 countries and territories around the world. Many people are asymptomatic or with mild symptoms. However, in some cases (usually the elderly and those with comorbidities) the disease may progress to pneumonia, acute respiratory distress syndrome and multi-organ dysfunction that can lead to death. Such wide interindividual differences in response to SARS-CoV-2 infection may relate to several pathogen- and host-related factors. These include the different levels of the ubiquitously present human angiotensin I converting enzyme 2 (ACE2) receptors gene expression and its variant alleles, the different binding affinities of ACE2 to the virus spike (S) protein given its L- and S-subtypes and the subsequent extent of innate immunity-related hypercytokinemia. The extensive synthesis of cytokines and chemokines in coronavirus diseases was suggested as a major factor in exacerbating lung damage and other fatal complications. The polymorphisms in genes coding for pro-inflammatory cytokines and chemokines have been associated with mediating the response and susceptibility to a wide range of infections and their severe outcomes. Understanding the nature of pathogen-host interaction in COVID-19 symptomatology together with the role of hypercytokinemia in disease severity may permit developing new avenues of approach for prevention and treatment and can delineate public health measures to control the spread of the disease.
Keywords: COVID-19; MERS-CoV; SARS-CoV; SARS-CoV-2; hypercytokinemia.
© 2020 Badawi.
Conflict of interest statement
The author declares no conflicts of interest.
Similar articles
-
An Assessment on Impact of COVID-19 Infection in a Gender Specific Manner.Stem Cell Rev Rep. 2021 Feb;17(1):94-112. doi: 10.1007/s12015-020-10048-z. Epub 2020 Oct 7. Stem Cell Rev Rep. 2021. PMID: 33029768 Free PMC article. Review.
-
Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.Trials. 2021 Jan 11;22(1):42. doi: 10.1186/s13063-020-04998-5. Trials. 2021. PMID: 33430924 Free PMC article.
-
Human and novel coronavirus infections in children: a review.Paediatr Int Child Health. 2021 Feb;41(1):36-55. doi: 10.1080/20469047.2020.1781356. Epub 2020 Jun 25. Paediatr Int Child Health. 2021. PMID: 32584199 Review.
-
COVID-19 and Individual Genetic Susceptibility/Receptivity: Role of ACE1/ACE2 Genes, Immunity, Inflammation and Coagulation. Might the Double X-chromosome in Females Be Protective against SARS-CoV-2 Compared to the Single X-Chromosome in Males?Int J Mol Sci. 2020 May 14;21(10):3474. doi: 10.3390/ijms21103474. Int J Mol Sci. 2020. PMID: 32423094 Free PMC article.
-
Contributions of human ACE2 and TMPRSS2 in determining host-pathogen interaction of COVID-19.J Genet. 2021;100(1):12. doi: 10.1007/s12041-021-01262-w. J Genet. 2021. PMID: 33707363 Free PMC article. Review.
Cited by
-
Determination role of some biomarkers tests for severe SARS-COV-2 infections in babylon province/IRAQ.Mater Today Proc. 2022;61:686-689. doi: 10.1016/j.matpr.2021.08.225. Epub 2021 Aug 28. Mater Today Proc. 2022. PMID: 34485097 Free PMC article.
-
Puerarin: A Potential Therapeutic for Colon Adenocarcinoma (COAD) Patients Suffering From SARS-CoV-2 Infection.Front Pharmacol. 2022 May 23;13:921517. doi: 10.3389/fphar.2022.921517. eCollection 2022. Front Pharmacol. 2022. PMID: 35677450 Free PMC article.
-
Inflammatory Cytokine: IL-17A Signaling Pathway in Patients Present with COVID-19 and Current Treatment Strategy.J Inflamm Res. 2020 Oct 6;13:673-680. doi: 10.2147/JIR.S278335. eCollection 2020. J Inflamm Res. 2020. PMID: 33116747 Free PMC article. Review.
-
ACE2 and TMPRSS2 SNPs as Determinants of Susceptibility to, and Severity of, a COVID-19 Infection.Br J Biomed Sci. 2022 Jan 12;79:10238. doi: 10.3389/bjbs.2021.10238. eCollection 2022. Br J Biomed Sci. 2022. PMID: 35996506 Free PMC article.
-
Comparative profile for COVID-19 cases from China and North America: Clinical symptoms, comorbidities and disease biomarkers.World J Clin Cases. 2021 Jan 6;9(1):118-132. doi: 10.12998/wjcc.v9.i1.118. World J Clin Cases. 2021. PMID: 33511177 Free PMC article.
References
LinkOut - more resources
Full Text Sources
Miscellaneous